EuBiologics Co., Ltd. (206650.KQ)
KRW 12130.0
(-3.58%)
KRW 12130.0
(-3.58%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 14.77 Billion KRW | -5.64% |
| 2022 | 15.66 Billion KRW | 0.91% |
| 2021 | 15.52 Billion KRW | -31.23% |
| 2020 | 22.57 Billion KRW | -39.57% |
| 2019 | 37.34 Billion KRW | 11.9% |
| 2018 | 33.37 Billion KRW | 924.6% |
| 2017 | 3.25 Billion KRW | -28.66% |
| 2016 | 4.56 Billion KRW | -54.93% |
| 2015 | 10.13 Billion KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 13.92 Billion KRW | -5.75% |
| 2024 Q2 | 13.38 Billion KRW | -3.91% |
| 2023 Q2 | 15.06 Billion KRW | -2.18% |
| 2023 Q3 | 14.84 Billion KRW | -1.48% |
| 2023 Q4 | 14.77 Billion KRW | -0.43% |
| 2023 Q1 | 15.4 Billion KRW | -1.66% |
| 2023 FY | 14.77 Billion KRW | -5.64% |
| 2022 Q2 | 15.74 Billion KRW | -1.93% |
| 2022 FY | 15.66 Billion KRW | 0.91% |
| 2022 Q4 | 15.66 Billion KRW | -0.25% |
| 2022 Q3 | 15.7 Billion KRW | -0.29% |
| 2022 Q1 | 16.05 Billion KRW | 3.45% |
| 2021 FY | 15.52 Billion KRW | -31.23% |
| 2021 Q3 | 15.21 Billion KRW | -25.93% |
| 2021 Q2 | 20.54 Billion KRW | -0.37% |
| 2021 Q4 | 15.52 Billion KRW | 2.0% |
| 2021 Q1 | 20.62 Billion KRW | 0.0% |
| 2020 FY | 22.57 Billion KRW | -39.57% |
| 2019 FY | 37.34 Billion KRW | 11.9% |
| 2018 FY | 33.37 Billion KRW | 924.6% |
| 2017 FY | 3.25 Billion KRW | -28.66% |
| 2016 FY | 4.56 Billion KRW | -54.93% |
| 2015 FY | 10.13 Billion KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 23.72 Billion KRW | 37.715% |
| CMG Pharmaceutical Co., Ltd. | 19.74 Billion KRW | 25.145% |
| Celltrion Pharm, Inc. | 162.52 Billion KRW | 90.907% |
| Huons Global Co., Ltd. | 254.93 Billion KRW | 94.203% |
| DongKook Pharmaceutical Co., Ltd. | 104.74 Billion KRW | 85.891% |
| Enzychem Lifesciences Corporation | 5.65 Billion KRW | -161.248% |
| Humedix Co., Ltd. | 2.7 Billion KRW | -447.008% |
| Boditech Med Inc. | 10.56 Billion KRW | -39.846% |
| FutureChem Co.,Ltd | 3.68 Billion KRW | -301.32% |
| Huons Co., Ltd. | 124.61 Billion KRW | 88.14% |
| BNC Korea Co., Ltd. | 737.2 Million KRW | -1904.7% |
| AptaBio Therapeutics Inc. | 13.93 Billion KRW | -6.062% |